Reconstituted High-Density Lipoproteins Rescue Diabetes-Impaired Endothelial Cell Metabolic Reprograming and Angiogenic Responses to Hypoxia
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025
DOI: 10.1161/atvbaha.124.320110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Khalia R Primer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia (K.R.P., J.T.M.T., V.A.N., L.G.S.…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Neovascularization, Physiologic, Lipoproteins, HDL, Ischemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Impaired angiogenic responses to ischemia underlie diabetic vascular complications. Reconstituted high-density lipoproteins (rHDLs) have proangiogenic effects in diabetes. The PDK4 (pyruvate dehydrogenase kinase 4)/PDC (pyruvate dehydrogenase complex) axis is an oxygen-conserving mechanism that preserves endothelial cell function in hypoxia. We aimed to determine the role of the PDK4/PDC axis in angiogenesis, the effect of diabetes on its regulation in response to ischemia, and the proangiogenic properties of rHDL. METHODS: Expression of PDK4 and phosphorylated PDC (pPDC) were measured in PBS- or rHDL-treated wounds of nondiabetic and streptozotocin-induced diabetic mice and PBS- or rHDL-treated endothelial cells exposed to glucose and hypoxia. The importance of PDK4 in the action of rHDL was determined by siRNA knockdown in vitro and PDK4 inhibitor in vivo. Chromatin immunoprecipitation assay was performed to identify the mechanism for PDK4 induction by rHDL. RESULTS: PDK4 and pPDC were elevated early (24 hours) post-induction of wound ischemia in nondiabetic wounds, which did not occur in diabetic mice. Topical rHDL rescued this impairment, enhancing PDK4 (68%; P =0.0041) and pPDC (165%; P =0.029) in diabetic wounds. Wound neovascularization (62%; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia (K.R.P., J.T.M.T., V.A.N., L.G.S., E.L.S., P.J.P., C.A.B.).
- Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Centre, Adelaide, Australia (K.R.P., J.T.M.T., L.S., V.A.N., L.G.S., E.L.S., P.J.P., C.A.B.).
- Centre of Excellence for Nanoscale Biophotonics, Adelaide, South Australia, Australia (K.R.P., V.A.N., C.A.B.).
ORCID-Profile: Khalia R Primer, Joanne T M Tan, Lauren Sandeman, Victoria A Nankivell, Liam G Stretton, Emma L Solly, Peter J Psaltis, Christina A Bursill
Zitieren
APA
Primer, K. R., Tan, J. T. M., Sandeman, L., Nankivell, V. A., Stretton, L. G., Solly, E. L., Psaltis, P. J., & Bursill, C. A. (2025). Reconstituted High-Density Lipoproteins Rescue Diabetes-Impaired Endothelial Cell Metabolic Reprograming and Angiogenic Responses to Hypoxia. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.320110
Vancouver
Primer KR, Tan JTM, Sandeman L, Nankivell VA, Stretton LG, Solly EL, et al. Reconstituted High-Density Lipoproteins Rescue Diabetes-Impaired Endothelial Cell Metabolic Reprograming and Angiogenic Responses to Hypoxia. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.124.320110
BibTeX
@article{Primer2025,
author = {Primer, Khalia R and Tan, Joanne T M and Sandeman, Lauren and Nankivell, Victoria A and Stretton, Liam G and Solly, Emma L and Psaltis, Peter J and Bursill, Christina A},
title = {Reconstituted High-Density Lipoproteins Rescue Diabetes-Impaired Endothelial Cell Metabolic Reprograming and Angiogenic Responses to Hypoxia},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
doi = {10.1161/atvbaha.124.320110}
}
EUVIMED